Cargando…

Evaluation of Chemotherapy Response with Serum Squamous Cell Carcinoma Antigen Level in Cervical Cancer Patients: A Prospective Cohort Study

MRI does not always reflect tumor response after chemotherapy. Therefore, it is necessary to explore additional parameters to more accurately evaluate tumor response for the subsequent clinical determination about radiotherapy or radical surgery. A training cohort and an external validation cohort w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yin, Mingzhu, Hou, Yan, Zhang, Tao, Cui, Changyi, Zhou, Xiaohua, Sun, Fengyu, Li, Huiyan, Li, Xia, Zheng, Jian, Chen, Xiuwei, Li, Cong, Ning, Xiaoming, Li, Kang, Lou, Ge
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3551772/ https://www.ncbi.nlm.nih.gov/pubmed/23349993 http://dx.doi.org/10.1371/journal.pone.0054969

Ejemplares similares

Could Adjuvant Chemotherapy Improve Prognosis for Cervical Cancer Patients with Elevated Pretreatment Serum Squamous-Cell Carcinoma Antigen?
por: Yuan, Zhen, et al.
Publicado: (2021)

The Predictive Value of Serum Squamous Cell Carcinoma Antigen in Patients with Cervical Cancer Who Receive Neoadjuvant Chemotherapy followed by Radical Surgery: A Single-Institute Study
por: Li, Xiong, et al.
Publicado: (2015)

Predictive value of microvessel features for the clinical response to neoadjuvant chemotherapy in cervical squamous carcinoma and the associations with prognosis
por: Li, Weili, et al.
Publicado: (2021)

The added value of fasting blood glucose to serum squamous cell carcinoma antigen for predicting oncological outcomes in cervical cancer patients receiving neoadjuvant chemotherapy followed by radical hysterectomy
por: Wu, Miao‐Fang, et al.
Publicado: (2019)

A Fifteen‐Gene Classifier to Predict Neoadjuvant Chemotherapy Responses in Patients with Stage IB to IIB Squamous Cervical Cancer
por: Tian, Xun, et al.
Publicado: (2021)

Serum squamous cell carcinoma antigen as an early indicator of response during therapy of cervical cancer
por: Markovina, Stephanie, et al.
Publicado: (2018)

A Comprehensive Analysis of Metabolomics and Transcriptomics in Cervical Cancer
por: Yang, Kai, et al.
Publicado: (2017)

E2F1/2/7/8 as independent indicators of survival in patients with cervical squamous cell carcinoma
por: Yang, Chang, et al.
Publicado: (2020)

Endu combined with concurrent chemotherapy and radiotherapy for stage IIB-IVA cervical squamous cell carcinoma patients
por: Zhao, Feng-Ju, et al.
Publicado: (2021)

Clinical utility of pretreatment serum squamous cell carcinoma antigen for prognostication and decision-making in patients with early-stage cervical cancer
por: Huang, Xiao-Dan, et al.
Publicado: (2023)

Squamous cell carcinoma antigen in cervical cancer and beyond
por: Kim, Byoung-Gie
Publicado: (2013)

A multicenter phase 2 trial of camrelizumab plus famitinib for women with recurrent or metastatic cervical squamous cell carcinoma
por: Xia, Lingfang, et al.
Publicado: (2022)

Serum lncRNAs (CCAT2, LINC01133, LINC00511) with Squamous Cell Carcinoma Antigen Panel as Novel Non-Invasive Biomarkers for Detection of Cervical Squamous Carcinoma
por: Wang, Wen-Jie, et al.
Publicado: (2020)

Optimal cutoff level of serum squamous cell carcinoma antigen to detect recurrent cervical squamous cell carcinoma during post-treatment surveillance
por: Oh, Jinju, et al.
Publicado: (2018)

Predictive value of preoperative serum squamous cell carcinoma antigen level for lymph node metastasis in early-stage cervical squamous cell carcinoma
por: Zhu, Chenggong, et al.
Publicado: (2021)

The simultaneous detection of the squamous cell carcinoma antigen and cancer antigen 125 in the cervical cancer serum using nano-Ag polydopamine nanospheres in an SERS-based lateral flow immunoassay
por: Xia, Ji, et al.
Publicado: (2020)

A Prognostic Nomogram for Cervical Cancer after Surgery from SEER Database
por: Wang, Ce, et al.
Publicado: (2018)

Postoperative serum squamous cell carcinoma antigen and carcinoembryonic antigen predict overall survival in surgical patients with esophageal squamous cell carcinoma
por: Huang, Yi, et al.
Publicado: (2023)

Clinical value of serum squamous cell carcinoma antigen levels in predicting chemosensitivity, lymph node metastasis, and prognosis in patients with cervical squamous cell carcinoma
por: Chen, Peng, et al.
Publicado: (2020)

Underdiagnosis of cervical intraepithelial neoplasia by colposcopy and its association with thin high‑grade squamous intraepithelial lesions
por: Li, Mingzhu, et al.
Publicado: (2023)

Pretreatment Squamous Cell Carcinoma Antigen (SCC-Ag) as a Predictive Factor for the Use of Consolidation Chemotherapy in Cervical Cancer Patients After Postoperative Extended-Field Concurrent Chemoradiotherapy
por: Zhang, Guangyu, et al.
Publicado: (2021)

Stratified treatment of localized cervical esophageal squamous cell carcinoma induced by neoadjuvant immunotherapy plus chemotherapy (SCENIC)
por: Li, Chunguang, et al.
Publicado: (2022)

Feature Quantification and Abnormal Detection on Cervical Squamous Epithelial Cells
por: Zhao, Mingzhu, et al.
Publicado: (2015)

Postoperative chemoradiotherapy is superior to postoperative chemotherapy alone in squamous cell lung cancer patients with limited N2 lymph node metastasis
por: Su, Liyu, et al.
Publicado: (2019)

Association and Effectiveness of PAX1 Methylation and HPV Viral Load for the Detection of Cervical High-Grade Squamous Intraepithelial Lesion
por: Li, Mingzhu, et al.
Publicado: (2022)

Cervical squamous cell carcinoma with isolated tibial metastasis: A case report and review of the literature
por: YUAN, FANG, et al.
Publicado: (2014)

Utility of serum squamous cell carcinoma antigen levels at the time of recurrent cervical cancer diagnosis in determining the optimal treatment choice
por: Shimura, Kotaro, et al.
Publicado: (2013)

Complementary Roles of Squamous Cell Carcinoma Antigen and (18)F-FDG PET/CT in Suspected Recurrence of Cervical Squamous Cell Cancer
por: Hu, Ying-Ying, et al.
Publicado: (2015)

Plasma lipid profiling and diagnostic biomarkers for oral squamous cell carcinoma
por: Wang, Lina, et al.
Publicado: (2017)

Diagnosis Value of Colposcope Combined with Serum Squamous Cell Carcinoma Antigen, Carbohydrate Antigen 125, and Carcinoembryonic Antigen for Moderate to Advanced Cervical Cancer Patients Treated with Modified Fuzheng Peiyuan Decoction
por: Meng, Huijuan, et al.
Publicado: (2021)

Use of serum squamous cell carcinoma antigen for follow-up monitoring of cervical cancer patients who were treated by concurrent chemoradiotherapy
por: Yoon, Sang Min, et al.
Publicado: (2010)

The Non-Cancer Specific Elevation of the Serum Squamous Cell Carcinoma Antigen during the Post-Radiotherapy Follow-Up of Cervical Cancer Patients
por: Oike, Tae, et al.
Publicado: (2021)

Role of APOA1 in the resistance to platinum-based chemotherapy in squamous cervical cancer
por: He, Yue, et al.
Publicado: (2022)

Prognostic significance of serum carcinoembryonic antigen and squamous cell carcinoma antigen in patients with esophageal squamous cell carcinoma undergoing radical esophagectomy
por: Hu, Jia, et al.
Publicado: (2020)

Effects of two genes coding squamous cell carcinoma antigen on the diagnosis and treatment of cervical squamous cell carcinoma
por: Yin, Qi’nan, et al.
Publicado: (2014)

The prognostic value of squamous cell carcinoma antigen for predicting tumor recurrence in cervical squamous cell carcinoma patients
por: Ryu, Hyun Kyung, et al.
Publicado: (2015)

Baseline immunity and impact of chemotherapy on immune microenvironment in cervical cancer
por: Zhang, Yi, et al.
Publicado: (2020)

Squamous cell carcinoma antigen expression in tumor cells is associated with the chemosensitivity and survival of patients with cervical cancer receiving docetaxel-carboplatin-based neoadjuvant chemotherapy
por: Chen, Peng, et al.
Publicado: (2017)

Use of Plasma Metabolomics to Identify Diagnostic Biomarkers for Early Stage Epithelial Ovarian Cancer
por: Fan, Lijun, et al.
Publicado: (2016)

Clinical value of routine serum squamous cell carcinoma antigen in follow-up of patients with locally advanced cervical cancer treated with radiation or chemoradiation
por: Oh, Jinju, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_7rd8odnvv3vhhldj0p9mae1jog